-- Thinkific Labs (THNC.TO) 周一盘后发布财报称，公司第一季度扭亏为盈，但营收增长，并任命 Leigh Ramsden 为首席财务官。 Ramsden 将于 6 月 1 日正式上任，接替此前担任临时首席财务官的 Kevin Wilson。根据声明，Wilson 将继续留在公司，担任高级财务顾问。 公司第一季度亏损 110 万美元，合每股亏损 0.02 美元，而去年同期净利润为 40.1 万美元，合每股收益 0.01 美元。FactSet 此前预计每股亏损 0.02 美元。 营收从去年同期的 1780 万美元增至 1870 万美元。FactSet 此前预计营收为 1860 万美元。 “我们第一季度业绩稳健，同时研发团队也进行了重大的人工智能驱动型变革。客户对我们人工智能教学助手 Thinker 的反馈验证了我们的投资以及人工智能战略的方向。我们看到人工智能投资带来了显著的生产力提升，这让我相信我们能够加快为客户和股东创造价值的速度，”首席执行官 Greg Smith 表示。 公司预计第二季度营收为 1820 万至 1850 万美元，调整后 EBITDA 为 -2% 至 -5%。 Thinkific 股票在多伦多证券交易所收盘上涨 0.04 加元，至 1.62 加元。
Related Articles
Asia
Westpac's Total Capital, CET1 Capital Up Year on Year in March Quarter
Westpac Banking (ASX:WBC, NZE:WBC) total capital and Common Equity Tier 1 (CET1) capital both increased year-over-year in the March quarter, according to a Tuesday Australian bourse filing.The bank's total capital in the three months to March came in at AU$98.54 billion, up from the AU$97.14 billion it reported in the year-ago period. Its CET1 capital for the period clocked in at AU$56.94 billion, rising from the AU$55.01 billion it reported for the March 2025 quarter.Its CET1 ratio for the March quarter was 12.4%, compared with a ratio of 12.2% in the prior-year period. It reported a liquidity coverage ratio of 132% for the quarter, compared with 135% in the same period in the previous year.
$ASX:WBC$NZE:WBC
Research
Research Alert: CFRA Raises Opinion On Shares Of Gildan Activewear To Buy From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month price target of CAD98, based on 16.0x our 2026 EPS estimate and above the company's five-year average forward P/E multiple of 12.9x, reflecting our view that the company deserves an above-peer multiple. We view the recent acquisition of HanesBrands as positive and believe the company will improve Hanes' operating efficiency while capitalizing on significant synergies. GIL reported Q1 2026 results that reflect the significant impact of its HanesBrands acquisition, with revenues increasing 64% to $1.17B, $18M above estimates, while facing substantial integration-related charges. Adjusted EPS from continuing operations declined to $0.43 from $0.59, $0.08 above consensus estimates, reflecting higher share count from the acquisition and ongoing integration expenses. We now view shares more positively after a 20% decline from its 52-week high just a few months ago. Shares currently trade at 13.5x the midpoint of the company's full-year EPS guidance.
$GIL
Asia
Medibank Private Reports Policyholder Growth in Nine Months to March 31, Maintains Outlook
Medibank Private (ASX:MPL) reported policyholder growth of 22,400 in its resident private health insurance business in the nine months to March 31, up 25% from the same period a year earlier, according to a Tuesday filing with the Australian bourse.The company said the resident private health insurance industry has become more competitive in recent months, with data showing consumers increasingly prioritizing value and some participants resorting to price-led customer propositions."While no new material trends have emerged in 2026, Medibank will continue to monitor utilization given historic behavior and competitor activity as we remain disciplined," it said.Medibank maintained its fiscal 2026 guidance, saying it does not expect global events and volatility to have a direct impact on its businesses.The company's main financial exposure is through its investment portfolio, which includes about AU$188 million of investments in equities, and through movements in Australia's cash rate where it flagged a roughly AU$7 million annual impact to investment income.
$ASX:MPL